Alpha 4-integrins mediate antigen-induced late bronchial responses and prolonged airway hyperresponsiveness in sheep. (original) (raw)
Research Article Free access | 10.1172/JCI117032
M W Sielczak, A Ahmed, A Cortes, I T Lauredo, J Kim, B Pepinsky, C D Benjamin, D R Leone, and R R Lobb
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Abraham, W. in:[JCI](/search/results?q=author.first%5Fname%3A%22W M%22+author.last%5Fname%3A%22Abraham%22&search%5Ftype=advanced) |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Sielczak, M. in:[JCI](/search/results?q=author.first%5Fname%3A%22M W%22+author.last%5Fname%3A%22Sielczak%22&search%5Ftype=advanced) |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Ahmed, A. in:JCI |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Cortes, A. in:JCI |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Lauredo, I. in:[JCI](/search/results?q=author.first%5Fname%3A%22I T%22+author.last%5Fname%3A%22Lauredo%22&search%5Ftype=advanced) |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Kim, J. in:JCI |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Pepinsky, B. in:JCI |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Benjamin, C. in:[JCI](/search/results?q=author.first%5Fname%3A%22C D%22+author.last%5Fname%3A%22Benjamin%22&search%5Ftype=advanced) |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Leone, D. in:[JCI](/search/results?q=author.first%5Fname%3A%22D R%22+author.last%5Fname%3A%22Leone%22&search%5Ftype=advanced) |PubMed |Google Scholar
Department of Medicine, University of Miami, Mount Sinai Medical Center, Florida 33140.
Find articles by Lobb, R. in:[JCI](/search/results?q=author.first%5Fname%3A%22R R%22+author.last%5Fname%3A%22Lobb%22&search%5Ftype=advanced) |PubMed |Google Scholar
Published February 1, 1994 -More info
Published February 1, 1994 -Version history
Eosinophils and T lymphocytes are thought to be involved in allergic airway inflammation. Both cells express the alpha 4 beta 1-integrin, very late antigen-4 (VLA-4, CD49d/CD29); alpha 4-integrins can promote cellular adhesion and activation. Therefore, we examined the in vivo effects of a blocking anti-alpha 4 monoclonal antibody, HP 1/2, on antigen-induced early and late bronchial responses, airway hyperresponsiveness, inflammatory cell influx, and peripheral leukocyte counts in allergic sheep. Sheep blood lymphocytes, monocytes, and eosinophils expressed alpha 4 and bound HP 1/2. In control sheep, Ascaris antigen challenge produced early and late increases in specific lung resistance of 380 +/- 42% and 175 +/- 16% over baseline immediately and 7 h after challenge, respectively, as well as airway hyperresponsiveness continuing for 14 d after antigen challenge. Treatment with HP 1/2 (1 mg/kg, i.v.) 30 min before antigen challenge did not affect the early increase in specific lung resistance but inhibited the late-phase increase at 5-8 h by 75% (P < 0.05) and inhibited the post-antigen-induced airway hyperresponsiveness at 1, 2, 7, and 14 d (P < 0.05, for each time). Intravenous HP 1/2 given 2 h after antigen challenge likewise blocked late-phase airway changes and postchallenge airway hyperresponsiveness. Airway administration of HP 1/2 (16-mg dose) was also effective in blocking these antigen-induced changes. Response to HP 1/2 was specific since an isotypic monoclonal antibody, 1E6, was ineffective by intravenous and aerosol administration. Inhibition of leukocyte recruitment did not totally account for the activity of anti-alpha 4 antibody since HP 1/2 neither diminished the eosinopenia or lymphopenia that followed antigen challenge nor consistently altered the composition of leukocytes recovered by bronchoalveolar lavage. Because airway administration of HP 1/2 was also active, HP 1/2 may have inhibited cell activation. Reduction of platelet-activating factor-induced eosinophil peroxidase release from HP 1/2-treated eosinophils supports such a mechanism. These findings indicate a role for alpha 4-integrins in processes that lead to airway late phase responses and persisting airway hyperresponsiveness after antigen challenge.
Images.
Click on an image below to see the page. View PDF of the complete article
- Version 1 (February 1, 1994): No description